Driver Killed in Rollover Crash on East Panama Lane

Posted on April 7, 2020April 7, 2020 by Staff Writer

Fashawn Pearson Arrested for DUI, Manslaughter in Fatal Bakersfield Accident

Bakersfield, CA (April 6, 2020) – One person was killed in a DUI crash in Bakersfield. The fatal accident occurred on the morning of April 6 on East Panama Lane.

Fashawn Pearson, 25, was driving an Audi when he hit a Toyota traveling in the same direction in the 3300 block of East Panama Lane. The Toyota overturned due to the impact. The driver died in the crash. Pearson was arrested for DUI resulting in death and gross vehicular manslaughter.

Our heartfelt condolences go out to the friends and loved ones of the victim.

Nadrich & Cohen is an active donor and supporter of several local MADD (Mothers Against Drunk Driving) chapters throughout California.

#Bakersfield

#93307

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

What can we do for you?

Answer your legal question.

Provide a Free Case Evaluation.

Schedule an appointment.

Why Choose Us?

Available 24/7

Trusted Since 1990

Local to You

Recovered $350,000,000

5 Star Reviews

Free Case Evaluation

VIP Service

No Win, No Fee

Latest Law Post

May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.

May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.